The therapeutic importance of compounds containing 1,2,3-triazoles is due to their spectrum of pharmacological activity, among which we can highlight the anticancer, antiviral, antibacterial, antifungal, anticonvulsant action, among others. The synthetic facility to obtain 1,2,3-triazoles through the 1,3-dipolar copper-catalyzed cycloaddition reaction (CuAAc), also called click chemistry, as well as the 1,3-dipolar thermal cycloaddition reaction, makes this group quite attractive as a pharmacophoric group. The present work has a general objective the planning, synthesis and evaluation of phenyl (1-phenyl-1H-1,2,3-triazoles-4-yl) methanol, also called hydroxy-1,2,3-triazoles, aiming to analyze their pharmacological actions against leishmaniasis. Two strategies were developed to obtain these compounds: (i) 1,3-dipolar copper-catalyzed cycloaddition reaction (CuAAC) between 1-phenyl-3- (trimethylsilyl) prop-2-in-1-ois and aryl azides substituted previously prepared thus leading to obtaining phenyl (1-phenyl-1H-1,2,3-triazoles-4-yl) methanol with yields between 20 and 30 percent. Aryl azides (50a-i) were prepared from anilines in 60 to 85 percent yields and 1-phenyl-3- (trimethylsilyl) prop-2-in-1-ois were prepared from the addition of ethinyltrimethylsilane to commercial benzaldehydes (ii) thermal cycloaddition reaction between aryl azides and (E) -3- (dimethylamino) -1-phenylprop- 2-en-1-one - previously prepared from 4-bromoacetophenones, in yields of 40-50 percent, followed by reduction of phenyl (1-phenyl-1H-1,2,3-triazoles-4- il) methanone with yields varying between 35-50 percent thus leading to the obtaining of phenyl (1-phenyl-1H-1,2,3-triazoles-4-yl) methanols with yields between 20 and 30 percent. The synthesized compounds were characterized by nuclear magnetic resonance (NMR), infrared (IR) and mass spectrometry (CG-MS) techniques.